Fingerprint
Dive into the research topics of 'Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically